Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective
Pérez Bianco, Rúl.; Ozelo, M.Castro.; Villaça, P.Ribeiro.; Solano, M.Helena.; Jimenez Cruze, G.; Martinez Murillo, C.; Garcia Chavez, J.; Mendoza, S.; Rodriguez Grecco, I.; Ruiz-Saez, A.
Medicina 68(3): 227-242
2008
ISSN/ISBN: 0025-7680 PMID: 18689157 Document Number: 621276
The Committee of Latin America on the Therapeutics of Inhibitor Groups (CLOTTING) is composed of a number of hemophilia specialists from Latin America. The group aims to encourage the adoption of a good standard of care for Latin American patients with hemophilia. The occurrence of inhibitors in patients with hemophilia poses clinical challenges, and it is estimated that between 1000 and 3000 patients in Latin America are affected by hemophilia with inhibitors. There is an urgent need to establish a regional consensus and clinical guidelines for the diagnosis and treatment of these patients. We present an extensive review based on best current clinical practice and published literature, as seen from a Latin American perspective, taking into account the variable nature of hemophilia care available in the various countries in this Region.